The cellular response to perturbations including environmental changes, toxins and mutations is typically complex and comprises signaling and metabolic changes, as well as changes in gene expression. Revealing the molecular mechanisms underlying cellular response to a specific perturbation may determine the nature of the perturbation, thus illuminating disease mechanisms 1 or a drug's mode of action 2, 3 , and identify points of intervention with potential therapeutic value 4 .
High-throughput experimental techniques are commonly used for finding components of these response pathways because they provide a genome-and proteome-wide view of molecular changes. mRNA profiling experiments rapidly identify genes that are differentially expressed following stimuli. Genetic screening, including deletion, overexpression and RNAi library screens, identify genetic 'hits', genes whose individual manipulation alters the phenotype of stimulated cells. However, each technique has obvious limitations for identifying the full nature of cellular responses. mRNA profiling experiments do not target the series of events that led to the differential expression. Genetic screens provide strong evidence that a gene is functionally related to the response process, but this relationship is often indirect and hard to decipher, especially in high-throughput experiments that typically result in scores of relevant genes with various functions.
It has been noted previously in a few specific instances 2,5-9 that genetic screens do not identify the same genes as mRNA assays conducted in the same conditions. Here we show that this discrepancy is, in fact, a general rule. Furthermore, we find a marked bias in each technique. We bridge this gap between the two forms of high-throughput data by using an algorithm that exploits molecular interactions data to reveal the functional context of genetic hits and additional proteins that participate in the response but that were not detected by either the genetic or the mRNA profiling assays themselves.
We applied the algorithm to identify cellular responses to increased expression of alpha-synuclein, a small human protein implicated in Parkinson's disease whose native function and role in the etiology of the disease remain unclear 10 . We screened an established yeast model for alpha-synuclein toxicity 11, 12 using an additional set of 3,500 overexpression yeast strains, exposing the multifaceted toxicity of alpha-synuclein. Application of our approach to the genetic hits from the screen and to transcriptional data of the yeast model provides the first cellular map of the proteins and genes responding to alpha-synuclein expression.
RESULTS

Comparing genetic hits and differentially expressed genes
We analyzed published mRNA profiles and genetic hits for 179 distinct perturbations in yeast (Methods). The perturbations included chemical and genetic insults affecting a multitude of cellular processes. Thirty of the genetic screens are complete, typically identifying 4100 genetic hits. In almost all cases the overlap was small and statistically insignificant ( Table 1 and Supplementary Table 1a online) .
We used Gene Ontology (GO) enrichment analysis to check whether each assay may be biased toward distinct aspects of cellular responses (Supplementary Table 1b and Supplementary Fig. 1a online). The combined genetic hits from all 179 genetic screens were highly enriched for several annotations, among the most frequent of which were biological regulation (23.3%, P o 10 À82 ), including transcription (14%, P o 10 À44 ) and signal transduction (6.3%, P o 10 À31 ). In contrast, the differentially expressed genes from all perturbations were enriched mostly for various metabolic processes (for example, organic acid metabolic process 7.1%, P o 10 À18 ) and oxidoreductase activities (7.2%, P o 10 À34 ). We observed the same enrichment trends upon focusing only on the 30 perturbations for which complete data were available when analyzed individually or when combined (Supplementary Tables 1 c,d and Supplementary Note online). Thus, we find that genetic assays tend to probe the regulation of cellular responses, whereas mRNA profiling assays tend to probe the metabolic aspects of cellular responses.
The differences in annotation between genetic hits and differentially expressed genes imply that each gene set alone often provides a limited and biased view of cellular responses. This hypothesis was confirmed in pathways that were well-studied by more classical methods. In the yeast DNA-damage response pathway, for example, a genetic screen 4 detected proteins that sense DNA damage (Mec3, Ddc1, Rad17 and Rad24), whereas mRNA profiling detected repair enzymes such as Rnr4 (ref. 13 ). Yet core components that had been uncovered by intense investigations over many years, such as the signal transducers Mec1 and Rad53 and the transcription factor Rfx1, remained undetected by either high-throughput assay.
To fully reap the benefits of applying highthroughput methods to new problems and underexplored biological processes, it is essential to find new routes to connect these data and obtain a true picture of the regulation of cellular responses. Judging from characterized pathways such as the DNA-damage response discussed above, we expect that some of the genetic hits, which are enriched for response regulators, will be connected via regulatory pathways to the differentially expressed genes, which are the output of such pathways, via components of the response that are missing from the experimental data ( Fig. 1) .
ResponseNet algorithm for identifying response networks
We devised the ResponseNet algorithm to identify molecular interaction paths connecting genetic hits and differentially expressed genes, including components of the response that are otherwise hidden (Fig. 1) . The yeast Saccharomyces cerevisiae provides a powerful model system for such analysis owing to the extensive molecular interactions data now available (Methods and Supplementary Table 2a online). We assembled an integrated network model of the yeast interactome that contains protein-protein interactions, metabolic relations and protein-DNA interactions detected by various methods with different levels of reliability 14 . The resulting interactome relates 5,622 interacting proteins and 5,510 regulated genes, which are represented by network nodes, via 57,955 molecular interactions, which are represented by network edges. Figure 1 Regulatory relationships between genetic and transcriptional data. Cellular response is depicted through a general signaling pathway, including receptor binding, transcription factor (TF) translocation into the nucleus and gene expression. Genetic screens and mRNA profiling identify only some of these molecular components and often do not identify the same genes, as shown. We find that the proteins products of genes identified in genetic screens (colored blue) tend to be molecules with regulatory roles. We therefore hypothesize that they may directly or indirectly contribute to the regulation of the observed change in gene expression (colored magenta).
ResponseNet identifies the likely regulatory pathways and predicts proteins that are part of these pathways even if they are not identified in either screen (colored red).
Our interactome representation has two important features that facilitate identification of pathways relating genetic hits to transcriptional changes. First, we highlighted the transcriptional regulatory role of proteins by representing differentially expressed genes and their protein products as separate gene and protein nodes, respectively. The only connection between protein and gene nodes is through edges representing observed protein-DNA interactions between transcriptional regulators and their target genes. Edges between two protein nodes represent other interaction types. Consequently, pathways connecting genetic hits to differentially expressed genes must pass through transcriptional regulators ( Supplementary Fig. 1b) . Second, because interactions vary in their reliability, each edge was given a weight that represents the probability that the connected nodes interact in a response pathway. Probabilities were computed using a Bayesian method that considers the experimental evidence supporting an interaction, and that favors interactions among proteins acting in a common cellular response pathway (Methods and Supplementary Table 2b) .
Because of the vast number of edges, a search for all interaction paths connecting the genetic hits to the differentially expressed genes typically results in 'hairball' networks that are very hard to interpret (Fig. 2a) . Pioneering approaches that searched an interactome for high-probability paths had to limit the output path lengths to three edges for computational complexity issues 15, 16 . We aimed for a solution that would (i) pick the subset of genetic hits most likely to modulate the differentially expressed genes without limiting it a priori to known regulatory genes, (ii) identify and rank intermediary proteins that are likely to be part of response pathways but escaped detection by high-throughput methods and (iii) give preference to proteins that lie on high-probability paths connecting the genetic hits to the differentially expressed genes without imposing constraints on the network topology.
These requirements were met with a 'flow algorithm' , a computational method used previously to analyze known signaling or metabolic pathways (for example, see ref. 17) . Basically, flow goes from a source node to a sink node through the graph edges; edges are associated with a capacity that limits the flow and with a cost. (As a loose analogy, this resembles water finding the path of least resistance through a complex landscape.) To identify response pathways we required that flow pass from genetic hits through interactome edges to differentially expressed genes ( Supplementary Fig. 1b ). We then formulated our goal as a minimum-cost flow optimization problem 18 : Cost was defined as the negative log of the probability of an edge. Hence, minimizing the cost gives preference to high-probability paths (Methods).
The solution to the optimization problem is a relatively sparse network connecting many of the genetic hits to many of the differentially expressed genes through known interactions and intermediary proteins (Fig. 2b) . Although these intermediary proteins escaped detection by either high-throughput genetic analysis or mRNA profiling, they are predicted by the algorithm to participate in the response. All proteins in the solution are ranked by the amount of flow they carry. The more flow that passes through a protein, the more important it is in connecting the input sets.
Validation of the ResponseNet algorithm
To determine whether ResponseNet provides valid biological insights, we used it to analyze data from perturbations of well-studied pathways. For example, we used ResponseNet to connect genetic hits associated with Ste5 (from the Saccharomyces Genome Database) and differentially expressed genes 19 collected from a strain lacking Ste5, a scaffold protein that coordinates the MAP kinase cascade activated by pheromone (Fig. 2b) . Nodes selected by ResponseNet were highly enriched for proteins functioning in the pheromone response pathway (46%, P o 10 À18 ), thus revealing the perturbed biological process. The highly ranked intermediary proteins included key regulators of the pheromone response including Ste5, the source of perturbation.
ResponseNet also performed well in analyzing the complex cellular response to DNA damage 4, 20, 21 . Nodes discovered by ResponseNet were highly enriched for the GO categories response to DNA damage stimulus (21%, P o 10 À14 ) and DNA repair (19%, P o 10 À14 ). The highly ranked part of the network contained core pathway proteins that were uncovered by years of intense investigation but escaped detection by high-throughput screens, including signal transducers (Mec1, Rad53), members of the RFC complex (Rfc2, Rfc3, Rfc4, Rfc5) and the transcriptional regulator Rfx1 (Fig. 2c) . Statistical evaluation of the performance of ResponseNet on data for less well-characterized pathways is described in the Supplementary Note.
Mapping the cellular responses to alpha-synuclein toxicity Having established the validity of our method to uncover connections between otherwise disparate high-throughput datasets, we applied ResponseNet to investigate the cellular toxicity associated with alphasynuclein (a-syn). a-Syn is a small lipid-binding protein that is natively unfolded when not bound to lipids and prone to forming toxic oligomers 22 . It has been implicated in several neurodegenerative disorders, particularly Parkinson's disease (PD): it is the main component of Lewy bodies, locus duplication or triplication of a-syn lead to familial forms of PD, and increased expression of a-syn leads to neurodegeneration in several animal models 23 . Despite immense efforts, the cellular pathways by which a-syn leads to cell death are just beginning to emerge.
The yeast Sacccharomyces cerevisiae provides a powerful system for studying the toxicities of a-syn that result from its intrinsic physical properties. Expression of human a-syn in yeast yields dosagedependent defects also found in mammalian systems, including cytosolic-lipid-droplet accumulation, reactive-oxygen-species production and ubiquitin-proteasome system impairment 11 . An initial screen for yeast genes that modify a-syn toxicity when overexpressed identified genes involved in ER-to-Golgi vesicle trafficking and led to the observation that a-syn blocks ER-to-Golgi vesicle trafficking 12 .
We now report the results of screening 5,500 overexpression yeast strains, thereby covering 85% of the yeast proteome. We identified 55 suppressors and 22 enhancers of a-syn toxicity, many with clear human orthologs, including the homolog of human PD gene ATP13A2 (also known as PARK9; Table 2 and Supplementary Table 3a online). As demonstrated in the accompanying article (Gitler et al. 24 ), PARK9 and the human homologs of eight other genetic modifiers with diverse functions (Ypt1, Hrd1, Ubp3, Pde2, Cdc5, Yck3, Sit4 and Pmr1) are efficacious in neuronal models, validating the yeast model as meaningful to a-syn toxicity in neurons 12, 24 . Major classes of genes that emerged include vesicle-trafficking genes, kinases and phosphatases, ubiquitin-related proteins, transcriptional regulators, manganese transporters and trehalose-biosynthesis genes (Supplementary Table 3a,b) . Notably, trehalose was recently shown to promote the clearance of misfolded mutant a-syn 25 , and manganese exposure has been linked with Parkinson's-like symptoms, albeit with a distinct underlying pathology 26 . The genes identified by the screen point to causal relations between a-syn expression and toxicities previously associated with PD but not specifically linked to a-syn (Supplementary Note).
mRNA profiling of the yeast model was determined in a separate study (unpublished data and Supplementary Table 3b,c). Upregulated genes prominently included genes with oxidoreductase activities (13%, P o 10 -9 ). Downregulated genes included ribosomal genes (28%, P o 10 -30 ), as commonly observed under stress 27 . More specific to a-syn toxicity, the downregulated genes were markedly enriched for genes encoding proteins localized to the mitochondria (60%, P o 10 -44 ). 
Manganese Immunoblotting against S-nitrosocysteine performed on a control strain (vector), on a strain expressing one copy of a-syn (NoTox) and on a high-toxicity strain (HiTox) expressing several copies of a-syn reveals that increasing levels of a-syn increase the amount of S-nitrosylated proteins.
The genetic and mRNA profiling data exemplify both the power and the limitations of the current approaches. Although they reveal the wide range of cellular functions altered by a-syn, the precise roles of the identified genes in the cellular response are unclear. For example, we checked whether the ubiquitin-related genetic hits affect a-syn degradation. However, in strains overexpressing these ubiquitinrelated genes, we did not detect changes in steady-state a-syn protein concentrations ( Supplementary Fig. 2 online) . As with our analyses above, the overlap between the genetic hits and the differentially expressed genes was minor (four genes, P ¼ 0.96).
Application of ResponseNet to these disparate datasets gave a more coherent view of the cellular response ( Supplementary Fig. 3a online) . The resulting network provided context to a large portion of the data: 34 (44%) genetic hits and 166 (27%) differentially expressed genes were linked to each other through 106 intermediary proteins. These include two-thirds of the protein kinase, phosphatase and ubiquitin-related genetic hits, illuminating their intricate role in the response to a-syn.
The major cellular pathways identified by ResponseNet included ubiquitin-dependent protein degradation, cell cycle regulation and vesicle-trafficking pathways, all of which have previously been associated with PD (Supplementary Note and Supplementary Fig. 3a) . Four examples illustrate the ability of ResponseNet to clarify aspects of a-syn responses relevant to PD and uncover others whose relationship to a-syn was completely unknown.
Nitrosative stress
Fzf1 was the only genetic hit related to nitrosative stress 28 . However, ResponseNet connected it to four upregulated transcripts, including that encoding Pdi1, a protein disulfide isomerase (PDI) (Fig. 3a) . Notably, the upregulation of human PDI protects neuronal cells from neurotoxicity associated with ER stress and protein misfolding (both of which are linked to a-syn expression in yeast and neurons), and PDI is one of a small number of specific proteins S-nitrosylated in PD that activate protective pathways, in addition to the generalized nitrosative damage that is a hallmark of the disease 29 . We found that increased expression of a-syn causes both specific and general increases in S-nitrosylation of proteins (Fig. 3b) . This was highly surprising because the yeast genome does not encode a canonical nitric oxide synthase and, until very recently, yeast were not thought to produce nitric oxide 30 . Our results indicate that the nitrosylation of specific proteins and generalized nitrosylation is a highly conserved and deeply rooted response to cellular perturbations created by a-syn.
Heat shock
The induction of the heat-shock response directly or via chemical inhibition of Hsp90 (ref. 31 ) suppresses a-syn toxicity in many model systems including yeast, flies, mice and human cells (for example, see refs. 32,33). However, heat-shock-related genes were conspicuously absent among the list of genetic suppressors. Nonetheless, ResponseNet predicted the involvement of two highly conserved heat-shock regulators, the chaperone Hsp90 (isoform Hsp82, Supplementary  Fig. 3a, panel a) and the heat-shock transcription factor Hsf1 (Fig. 4a) . Hsf1 appeared downstream of the toxicity suppressor Gip2, a putative regulatory subunit of the Glc7 phosphatase, which interacts with Gac1. Gac1 is a regulatory subunit of the Glc7 complex that is known to activate Hsf1 (ref. 34 ). These connections suggested that Gip2 overexpression might induce a heat-shock response. Indeed, we found that strains overexpressing Gip2 show elevated concentrations of heat-shock proteins (Fig. 4b) . ResponseNet therefore provided a mechanistic explanation for the suppression of a-syn toxicity achieved by Gip2 overexpression and identified a new regulator of the highly conserved heat-shock response.
The mevalonate-ergosterol biosynthesis pathway
This pathway, which is targeted by the cholesterol-lowering statin drugs, synthesizes sterols as well as other products with connections to a-syn toxicity, such as farnesyl groups required for vesicle trafficking proteins and ubiquinone required for mitochondrial respiration. ResponseNet ranked highly Hrd1, which regulates the protein target of statins, and the predicted intermediary Hap1, a proposed transcriptional regulator of the pathway 35 ( Supplementary Fig. 3a, panel a) . In addition, the a-syn mRNA profile modestly correlated with the profile of yeast treated with lovastatin (r ¼ 0.32, P o 10 À93 , L.J.S. and S.L., unpublished data), and several genetic hits also could be associated with products of the pathway (enzymes Bet4 and Cax4, farnesylated proteins Ypt1 and Ykt6 and putative sterol carriers Sut2, Osh2 and Osh3). We therefore tested the effect of lovastatin, which selectively inhibits the highly conserved HMG-CoA reductase protein in yeast and in mammalian cells, on a-syn toxicity. Addition of 5 mM lovastatin to the media caused a further reduction in growth to strains overexpressing a-syn (Fig. 5a ), but did not reduce growth of either wild-type controls or of cells expressing another toxic protein, a glutamine-expansion variant of huntingtin exon I 36 ( Supplementary  Fig. 3b ). We further tested ubiquinone, a downstream output of this pathway, reasoning that its downregulation through the action of a-syn might increase cellular vulnerability. Indeed, the addition of ubiquinone-2 to the media provided a modest suppression against a-syn toxicity. Ubiquinone is an antioxidant, but this was not a nonspecific antioxidant response, as the antioxidant N-acetylcysteine had no effect (data not shown). ( Fig. 5b) . We found that addition of the TOR-inhibitor rapamycin to the media markedly enhanced the toxicity of a-syn. Indeed, a low dose of a-syn, which is otherwise innocuous, became toxic (Fig. 5c) . Establishing the specificity of this effect to a-syn, rapamycin did not reduce growth of cells expressing glutamine expansion variants of huntingtin exon I ( Supplementary Fig. 3c ). As other studies have suggested benefits of rapamycin treatment in PD models, these results call for further investigation and suggest a complexity to the response to rapamycin that is potentially due to the vast range of processes affected by TOR activation.
The target of rapamycin (TOR) pathway
DISCUSSION
We provide a novel framework in which genetic, physical and transcriptional data naturally complement each other in the context of cellular response to biological perturbations. Although the complementary nature of these data has been noted 2,5-9,37 , a systematic analysis of the relationship between stimulus-specific genetic modifiers and transcriptional responses has been lacking. By examining over 150 distinct stimuli we find that differentially expressed genes and genetic hits are consistently disparate ( Table 1) ; genetic hits are biased toward regulatory proteins, whereas the differentially expressed genes are biased toward metabolic processes. Indeed, each assay has inherent 'blind spots' . Many yeast regulatory proteins are not detected by transcriptional assays because either they are predominantly regulated post-transcriptionally, they have a low transcript concentration 38 or their differential expression is transient, making changes hard to measure. Conversely, the genes that are differentially transcribed are often involved in metabolic processes or redundant functions, which tend to be robust against single mutations 39 .
The discordance between genetic hits and differentially expressed genes has implications for the search for therapeutic strategies. In yeast, inactivating a differentially expressed gene is no more likely to affect cell viability than targeting a randomly chosen gene. Bridging the gap between these data using techniques like ResponseNet can potentially reveal intervention points not discovered in the highthroughput assays themselves (Fig. 2) that may be targeted by drugs.
Our computational approach is based on a flow algorithm to connect the genetic hits and differentially expressed genes. Unlike studies that link a target gene with its causal transcriptional change 13, 15, 16, [40] [41] [42] [43] , a flow-based approach allows for a global, efficient and simultaneous solution for multiple target genes that puts no a priori bounds on the structure of the output. Indeed, the predicted output networks have rich structures with half of all paths having a length of three edges or more. The ability of ResponseNet to analyze interactome data containing tens of thousands of nodes and edges make it well suited to analyzing the accumulating data from other species or other techniques.
We applied our approach to a yeast model for a-syn pathobiology implicated in PD. Our unbiased screen identified 77 genes whose overexpression altered a-syn toxicity ( Table 2) . These included genes involved in vesicle trafficking (as previously reported), protein degradation, cell cycle regulation, nitrosative stress, osmolyte biosynthesis and manganese transport. This screen established an interface between a-syn and a large number of cellular and environmental factors previously linked to neuropathology and, in some cases, specifically to parkinsonism, but not specifically linked to a-syn. Many of the genes we identified are highly conserved in humans, where they may exert similar effects. Indeed, eight out of nine toxicity modifiers tested had similar effects on a-syn toxicity in yeast and in neuronal systems 24 .
Application of ResponseNet to the a-syn model successfully provided functional context to many of the genetic hits identified in our yeast screen (Supplementary Fig. 3a ) and pointed to the involvement of several cellular pathways (Figs. 3-5 ). Of these, the mevalonateergosterol pathway is of special interest as its perturbation could potentially alter a variety of downstream pathways, including protein farnesylation and ubiquinone biosynthesis, which are closely related to the vesicle trafficking defects and mitochondrial dysfunction observed in the yeast model. Indeed, a link between sterol biosynthesis and the etiology of PD has recently emerged. Individuals with PD have significantly lower concentrations of low-density lipoprotein (LDL) cholesterol than their spouses 44 , and low concentrations of LDL preceded the appearance of PD in a group of men of Japanese ancestry 45 . Our work provides a molecular framework for elucidating this connection.
The global picture obtained by integrating high-throughput genetic, transcriptional and physical data demonstrates the power of integrative approaches to illuminate underexplored cellular processes. As high-throughput assays are becoming routine in the study of complex disease and developmental processes, approaches for deciphering these data based on their underlying characteristics are vital. 
METHODS
where
We assumed conditionally independence between different types of evidence:
Interactions between protein and gene nodes. Weights were designed to reflect the reliability of the interaction on the basis of experimental evidence and bindingsite conservation. The scheme for calculating P(RP) and P(I k | RP) and the weights per interaction type appear in the Supplementary Note. Because high edge weights could indicate unusually well-studied proteins 46 or imperfectness of the assumption of conditional independence, all weights were capped to a maximum value of 0.7.
Linear programming formulation. For each perturbation, the input to ResponseNet consisted of the weighted interactome G ¼ (V, E), the genetic hits GenCV and the differentially expressed genes TraCV identified following the perturbation. Each edge (i, j) AE was characterized by a weight w ij and a capacity c ij ¼ 1.
The graph G was updated as follows: 1. V¢ ¼ V , {S, T}, where S and T are auxiliary nodes representing the source and sink, respectively.
2. E¢ ¼ E,(S,i) 8iAGen ,(i,T) 8iATra , connecting S to the genetic hits and T to the differentially expressed genes by directed edges.
3.
8iAGen, where the strength of each genetic hit was measured by the variation it conferred on the number of colonies per drop if available; otherwise, strengths were uniform. 4.
c iT ¼ log 2 ðstrength i Þ P j2Tra log 2 ðstrength j Þ ; 8iATra, where the strength was measured by either the relative change in its transcript level or the P value associated with it, depending on their availability. 5. w Si ¼ c Si 8iAGen and w iT ¼ c iT 8iATra Letting f ij denote the flow from node i to node j and for any given g Z 0, the following optimization problem was solved using LOQO 47 :
The solution F ¼ {f ij 4 0} defined the predicted response network. For enrichment analysis only protein nodes were considered, and genetic hits were included only if they received flow from nodes other than the source. Protein nodes were ranked in decreasing order according to the total amount of their incoming flow. Although the solution to the optimization problem is a directed network, this directionality only reflects the way in which the algorithm directed flow from the genetic hits to the differentially expressed genes and does not represent the causal order of events ( Supplementary Fig. 1b) . Additional information regarding the formulation, space of solutions, setting g value and ResponseNet performance appear in the Supplementary Note. For ResponseNet validation g ¼ 10.
Statistical analysis. Probabilities of overlap between genetic hits and differentially expressed genes were calculated using Fisher's exact test, given a total of 6,000 yeast genes. Enrichment analysis was done using the Gene Ontology Term Finder from SGD. a-Syn toxicity modifier screen The high-throughput yeast transformation protocol appears elsewhere 12 .
Immunoblotting. Phosphoglycerate kinase 1(Pgk1) mouse monoclonal antibody was used at 1:5000. Hsp26 rabbit polyclonal antibody (gift from J. Buchner, Center for Integrative Protein Science and Department of Chemistry, Technische Universität München) was used at 1:5000. Hsp104 mouse monoclonal antibody (4B; ref. 48 ) was used at 1:5000. S-nitosocysteine rabbit polyclonal antibody (Sigma) was used at 1:10,000.
a-Syn ResponseNet analysis. Differentially expressed genes had at least a twofold change in expression with P value r0.05 (Supplementary Table 3c ). Capacities of edges connecting the source to genetic hits were relative to the absolute strength of the genetic hits (Supplementary Table 3a ). Capacities of edges connecting differentially expressed genes to the sink were relative to the absolute log of the change in expression. We repeated the analysis excluding nonspecific stress responses (Supplementary Note). ResponseNet was run with g ¼ 12.
a-Syn growth in presence of small molecules. For spotting assays, yeast strains were initially grown to saturation in media containing raffinose, normalized for their A 600 and serially diluted by fivefold before spotting onto appropriate yeast media. Growth curves were monitored using the Bioscreen instrument. Yeast strains were pre-grown in 2% raffinose medium and induced in 2% galactose medium in presence of either the compound or vehicle control (1% DMSO final) with starting A 600 of 0.1. Cells were grown at 30 1C, with plates shaken every 30 s to ensure proper aeration and A 600 measurements taken every half hour over a 2-d period. The resulting data (A 600 versus time) were plotted using Kaleidagraph. At least three independent runs were conducted for each growth condition.
Note: Supplementary information is available on the Nature Genetics website. 
